Literature DB >> 11945184

Effect of anti-fungal nasal lavage with amphotericin B on nasal polyposis.

Alma Ricchetti1, Basile N Landis, Alessandra Maffioli, Roland Giger, Chungkuan Zeng, Jean-Silvain Lacroix.   

Abstract

Recent studies have suggested that allergic fungal rhino-sinusitis could be involved in the development of nasal polyposis. The aim of this study was to evaluate the response of anti-fungal nasal lavages. Patients performed nasal lavage with 20 ml of a one per one thousand amphotericin B suspension in each nostril, twice a day, for four weeks. In addition, all patients continued their saline nasal lavage and their conventional topical corticosteroid spray. This study included 74 patients, with a mean age of 46 years (range from 19 to 73). Before anti-fungal treatment, the distribution of nasal polyposis, according to Malm, was: 13 patients in stage I (17.5 per cent), 48 patients in stage II (65 per cent) and 13 patients in stage III (17.5 per cent). After anti-fungal nasal lavages, the total disappearance of nasal polyposis was observed in 29 patients (39 per cent). Eight patients were stage I, 21 stage II, and none stage III. In patients who have had previous endoscopic polypectomy and functional endoscopic sinus surgery, total disappearance of nasal polyposis was seen in 24 patients (47 per cent). Hyper-reactivity to fungal organisms could be one of the mechanisms underlying the development of nasal polyposis. A direct effect of amphotericin B suspension on the integrity of the cell membrane of the polyps' epithelium could not be excluded.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11945184     DOI: 10.1258/0022215021910708

Source DB:  PubMed          Journal:  J Laryngol Otol        ISSN: 0022-2151            Impact factor:   1.469


  16 in total

Review 1.  Role of medical therapy in the management of nasal polyps.

Authors:  Isam Alobid; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2012-04       Impact factor: 4.806

2.  Clinical subgroups and antifungal susceptibilities in fungal culture-positive patients with chronic rhinosinusitis.

Authors:  Selim S Erbek; Kivanc Serefhanoglu; Seyra Erbek; Muge Demirbilek; Fusun Can; Erkan Tarhan; Hale Turan; Ozcan Cakmak
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-11-28       Impact factor: 2.503

3.  The mold conundrum in chronic hyperplastic sinusitis.

Authors:  Fenna A Ebbens; Christos Georgalas; Wytske J Fokkens
Journal:  Curr Allergy Asthma Rep       Date:  2009-03       Impact factor: 4.806

4.  A 42-year-old woman with chronic rhinosinusitis and allergic mucin.

Authors:  Kimberly C Salazar; Michael R Nelson; Kelly D Stone
Journal:  Curr Allergy Asthma Rep       Date:  2009-07       Impact factor: 4.806

Review 5.  The role of ubiquitous airborne fungi in chronic rhinosinusitis.

Authors:  Jens U Ponikau; David A Sherris; Gail M Kephart; Cheryl Adolphson; Hirohito Kita
Journal:  Clin Rev Allergy Immunol       Date:  2006-06       Impact factor: 8.667

Review 6.  Fungal Rhinosinusitis: Unravelling the Disease Spectrum.

Authors:  Virendra Singh
Journal:  J Maxillofac Oral Surg       Date:  2019-01-28

7.  Postoperative application of amphotericin B nasal spray in chronic rhinosinusitis with nasal polyposis, with a review of the antifungal therapy.

Authors:  I Gerlinger; A Fittler; F Fónai; A Patzkó; A Mayer; L Botz
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-10-25       Impact factor: 2.503

Review 8.  The mold conundrum in chronic rhinosinusitis: where do we stand today?

Authors:  Fenna A Ebbens; Wytske J Fokkens
Journal:  Curr Allergy Asthma Rep       Date:  2008-04       Impact factor: 4.806

9.  Antifungal treatment and chronic rhinosinusitis.

Authors:  Devyani Lal; James A Stankiewicz
Journal:  Curr Allergy Asthma Rep       Date:  2009-05       Impact factor: 4.806

Review 10.  Differential diagnosis of eosinophilic chronic rhinosinusitis.

Authors:  John C Sok; Berrylin J Ferguson
Journal:  Curr Allergy Asthma Rep       Date:  2006-05       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.